Microbiological outcome at TOC visit | Clinical outcome at LFU visit | % Difference in relapse between persisted and eradicated (95% CI) | ||
---|---|---|---|---|
Sustained | Indeterminate | Relapse | ||
Eradicated, n/N (%) | 225/229 (98.3) | 1/229 (0.4) | 3/229 (1.3) | 17.2 (8.7–29.6) |
Persisted, n/N (%) | 42/54 (77.8) | 2/54 (3.7) | 10/54 (18.5) |